Cargando…
Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control
The objective of the current research was to develop a liquid chromatography-MS(n) (LC-MS(n)) methodology for the determination of free cortisol and its 15 endogenous metabolites (6β-hydroxycortisol, 20α-dihydrocortisol, 20α-dihydrocortisone, 20-β-dihydrocortisol, 20β-dihydrocortisone, prednisolone,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436849/ https://www.ncbi.nlm.nih.gov/pubmed/35915250 http://dx.doi.org/10.1007/s00216-022-04249-3 |
_version_ | 1784781465220808704 |
---|---|
author | Arioli, Francesco Gamberini, Maria Cristina Pavlovic, Radmila Di Cesare, Federica Draghi, Susanna Bussei, Giulia Mungiguerra, Francesca Casati, Alessio Fidani, Marco |
author_facet | Arioli, Francesco Gamberini, Maria Cristina Pavlovic, Radmila Di Cesare, Federica Draghi, Susanna Bussei, Giulia Mungiguerra, Francesca Casati, Alessio Fidani, Marco |
author_sort | Arioli, Francesco |
collection | PubMed |
description | The objective of the current research was to develop a liquid chromatography-MS(n) (LC-MS(n)) methodology for the determination of free cortisol and its 15 endogenous metabolites (6β-hydroxycortisol, 20α-dihydrocortisol, 20α-dihydrocortisone, 20-β-dihydrocortisol, 20β-dihydrocortisone, prednisolone, cortisone, α-cortolone, β-cortolone, allotetrahydrocortisol, 5α-dihydrocortisol, tetrahydrocortisol, allotetrahydrocortisone, 5β-dihydrocortisol, tetrahydrocortisone) in human urine. Due to its optimal performance, a linear ion trap operating in ESI negative ion mode was chosen for the spectrometric analysis, performing MS(3) and MS(4) experiments. The method was validated for limit of detection (LOD) and limit of quantification (LOQ) (0.01 ng mL(−1) and 0.05 ng mL(−1), for all compounds, respectively), intra- and inter-day precision (CV = 1.4–9.2% and CV = 3.6–10.4%, respectively), intra- and inter-day accuracy (95–110%), extraction recovery (65–95%), linearity (R2 > 0.995), and matrix effect that was absent for all molecules. Additionally, for each compound, the percentage of glucuronated conjugates was estimated. The method was successfully applied to the urine (2 mL) of 50 healthy subjects (25 males, 25 females). It was also successfully employed on urine samples of two patients with Cushing syndrome and one with Addison’s disease. This analytical approach could be more appropriate than commonly used determination of urinary free cortisol collected in 24-h urine. The possibility of considering the differences and relationship between cortisol and its metabolites allows analytical problems related to quantitative analysis of cortisol alone to be overcome. Furthermore, the developed method has been demonstrated as efficient for antidoping control regarding the potential abuse of corticosteroids, which could interfere with the cortisol metabolism, due to negative feedback on the hypothalamus-hypophysis-adrenal axis. Lastly, this method was found to be suitable for the follow-up of prednisolone that was particularly important considering its pseudo-endogenous origin and correlation with cortisol metabolism. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9436849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-94368492022-09-03 Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control Arioli, Francesco Gamberini, Maria Cristina Pavlovic, Radmila Di Cesare, Federica Draghi, Susanna Bussei, Giulia Mungiguerra, Francesca Casati, Alessio Fidani, Marco Anal Bioanal Chem Research Paper The objective of the current research was to develop a liquid chromatography-MS(n) (LC-MS(n)) methodology for the determination of free cortisol and its 15 endogenous metabolites (6β-hydroxycortisol, 20α-dihydrocortisol, 20α-dihydrocortisone, 20-β-dihydrocortisol, 20β-dihydrocortisone, prednisolone, cortisone, α-cortolone, β-cortolone, allotetrahydrocortisol, 5α-dihydrocortisol, tetrahydrocortisol, allotetrahydrocortisone, 5β-dihydrocortisol, tetrahydrocortisone) in human urine. Due to its optimal performance, a linear ion trap operating in ESI negative ion mode was chosen for the spectrometric analysis, performing MS(3) and MS(4) experiments. The method was validated for limit of detection (LOD) and limit of quantification (LOQ) (0.01 ng mL(−1) and 0.05 ng mL(−1), for all compounds, respectively), intra- and inter-day precision (CV = 1.4–9.2% and CV = 3.6–10.4%, respectively), intra- and inter-day accuracy (95–110%), extraction recovery (65–95%), linearity (R2 > 0.995), and matrix effect that was absent for all molecules. Additionally, for each compound, the percentage of glucuronated conjugates was estimated. The method was successfully applied to the urine (2 mL) of 50 healthy subjects (25 males, 25 females). It was also successfully employed on urine samples of two patients with Cushing syndrome and one with Addison’s disease. This analytical approach could be more appropriate than commonly used determination of urinary free cortisol collected in 24-h urine. The possibility of considering the differences and relationship between cortisol and its metabolites allows analytical problems related to quantitative analysis of cortisol alone to be overcome. Furthermore, the developed method has been demonstrated as efficient for antidoping control regarding the potential abuse of corticosteroids, which could interfere with the cortisol metabolism, due to negative feedback on the hypothalamus-hypophysis-adrenal axis. Lastly, this method was found to be suitable for the follow-up of prednisolone that was particularly important considering its pseudo-endogenous origin and correlation with cortisol metabolism. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-08-02 2022 /pmc/articles/PMC9436849/ /pubmed/35915250 http://dx.doi.org/10.1007/s00216-022-04249-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Paper Arioli, Francesco Gamberini, Maria Cristina Pavlovic, Radmila Di Cesare, Federica Draghi, Susanna Bussei, Giulia Mungiguerra, Francesca Casati, Alessio Fidani, Marco Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control |
title | Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control |
title_full | Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control |
title_fullStr | Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control |
title_full_unstemmed | Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control |
title_short | Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control |
title_sort | quantification of cortisol and its metabolites in human urine by lc-ms(n): applications in clinical diagnosis and anti-doping control |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436849/ https://www.ncbi.nlm.nih.gov/pubmed/35915250 http://dx.doi.org/10.1007/s00216-022-04249-3 |
work_keys_str_mv | AT ariolifrancesco quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol AT gamberinimariacristina quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol AT pavlovicradmila quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol AT dicesarefederica quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol AT draghisusanna quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol AT busseigiulia quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol AT mungiguerrafrancesca quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol AT casatialessio quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol AT fidanimarco quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol |